Zhixia Qiu

1.4k total citations · 1 hit paper
65 papers, 1.1k citations indexed

About

Zhixia Qiu is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Zhixia Qiu has authored 65 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 19 papers in Oncology and 10 papers in Pharmacology. Recurrent topics in Zhixia Qiu's work include Liver Disease Diagnosis and Treatment (7 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Traditional Chinese Medicine Analysis (5 papers). Zhixia Qiu is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Traditional Chinese Medicine Analysis (5 papers). Zhixia Qiu collaborates with scholars based in China, Japan and United States. Zhixia Qiu's co-authors include Fang Huang, Xijing Chen, Zhiyu Li, Yu Dai, Ning Li, Baolin Liu, Jinlei Bian, Ning Li, Xiaonan Li and Yang Lu and has published in prestigious journals such as Nature, Advanced Drug Delivery Reviews and Journal of Agricultural and Food Chemistry.

In The Last Decade

Zhixia Qiu

62 papers receiving 1.1k citations

Hit Papers

A polyene macrolide targeting phospholipids in the fungal... 2025 2026 2025 5 10 15 20
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A polyene macrolide targeting phospholipids in the fungal cell membrane
    2025 20 citations Zhixia Qiu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhixia Qiu China 21 448 185 159 155 108 65 1.1k
Jingwei Tian China 22 497 1.1× 213 1.2× 102 0.6× 90 0.6× 96 0.9× 52 1.1k
Lijun Zhang China 22 722 1.6× 194 1.0× 191 1.2× 105 0.7× 150 1.4× 63 1.4k
Qianmei Zhou China 18 585 1.3× 134 0.7× 133 0.8× 183 1.2× 105 1.0× 45 1.0k
Feng Jin China 22 558 1.2× 252 1.4× 265 1.7× 97 0.6× 105 1.0× 73 1.3k
Shaoyu Wu China 16 536 1.2× 161 0.9× 72 0.5× 101 0.7× 79 0.7× 54 1.0k
Amir R. Afshari Iran 25 753 1.7× 219 1.2× 190 1.2× 164 1.1× 109 1.0× 76 1.7k
Jiayi Sun China 20 570 1.3× 104 0.6× 159 1.0× 172 1.1× 79 0.7× 77 1.3k
Jianxin Pang China 23 630 1.4× 108 0.6× 240 1.5× 72 0.5× 108 1.0× 87 1.4k
Lipeng Xu China 22 503 1.1× 118 0.6× 135 0.8× 100 0.6× 96 0.9× 57 1.3k
Anna L. Greenshields Canada 16 550 1.2× 159 0.9× 167 1.1× 118 0.8× 65 0.6× 41 1.2k

Countries citing papers authored by Zhixia Qiu

Since Specialization
Citations

This map shows the geographic impact of Zhixia Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhixia Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhixia Qiu more than expected).

Fields of papers citing papers by Zhixia Qiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhixia Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhixia Qiu. The network helps show where Zhixia Qiu may publish in the future.

Co-authorship network of co-authors of Zhixia Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhixia Qiu. A scholar is included among the top collaborators of Zhixia Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhixia Qiu. Zhixia Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Mengdi, Yuanyuan Lei, Tao Yang, et al.. (2025). Dual inhibition of hepatic ACLY and ACSS2: A synergistic approach to combat NAFLD through lipogenesis reduction and mitochondrial enhancement. Pharmacological Research. 215. 107706–107706. 1 indexed citations
2.
Zhang, Yanqing, Wenjing Liu, Chao Tong, et al.. (2025). Design and Discovery of Preclinical Candidate LYG-409 as a Highly Potent and Selective GSPT1 Molecular Glue Degraders. Journal of Medicinal Chemistry. 68(3). 2608–2638. 4 indexed citations
3.
Zhang, Xiankang, Hui Zhang, Yu Li, et al.. (2024). Addressing Clinical Limitations of Glutaminase Inhibitors: Novel Strategies for Osimertinib‐Resistant Lung Cancer by Exploiting Glutamine Metabolic Dependency. Advanced Science. 12(6). e2411479–e2411479. 6 indexed citations
4.
Guo, Huimin, et al.. (2024). Discovery of Highly Potent Solute Carrier 13 Member 5 (SLC13A5) Inhibitors for the Treatment of Hyperlipidemia. Journal of Medicinal Chemistry. 67(8). 6687–6704.
5.
Zhang, Jingwei, Zhixia Qiu, Yongjie Zhang, Guangji Wang, & Haiping Hao. (2023). Intracellular spatiotemporal metabolism in connection to target engagement. Advanced Drug Delivery Reviews. 200. 115024–115024. 6 indexed citations
6.
Liu, Dongyu, Bin Yu, Xin‐Yuan Guan, et al.. (2023). Discovery of a photoactivatable dimerized STING agonist based on the benzo[b]selenophene scaffold. Chemical Science. 14(15). 4174–4182. 12 indexed citations
7.
Zhang, Mengdi, Yuanyuan Lei, Wenjun Hu, et al.. (2023). Corydalis saxicola Bunting total alkaloids improve NAFLD by suppressing de novo lipogenesis through the AMPK-SREBP1 axis. Journal of Ethnopharmacology. 319. 117162–117162. 14 indexed citations
8.
Cao, Yaqi, et al.. (2022). Contributions of intestine and liver to the absorption and disposition of FZJ-003, a selective JAK1 inhibitor with structure modification of filgotinib. European Journal of Pharmaceutical Sciences. 175. 106211–106211. 2 indexed citations
9.
Yuan, Kai, Shengnan Xie, Zhixia Qiu, et al.. (2021). Discovery of Dual CDK6/PIM1 Inhibitors with a Novel Structure, High Potency, and Favorable Druggability for the Treatment of Acute Myeloid Leukemia. Journal of Medicinal Chemistry. 65(1). 857–875. 13 indexed citations
10.
11.
Chen, Xin, Raphael R. Steimbach, Tong Wu, et al.. (2019). Novel 2, 5-diketopiperazine derivatives as potent selective histone deacetylase 6 inhibitors: Rational design, synthesis and antiproliferative activity. European Journal of Medicinal Chemistry. 187. 111950–111950. 38 indexed citations
12.
Lu, Xiaoyu, Min Fang, Zhixia Qiu, et al.. (2018). PEGylated Triacontanol Substantially Enhanced the Pharmacokinetics of Triacontanol in Rats. Journal of Agricultural and Food Chemistry. 66(33). 8722–8728. 5 indexed citations
13.
Yu, Jiaojiao, Qiuyan Liu, Xiaoyu Lu, et al.. (2018). Inhibitory and inductive effects of Corydalis saxicola Bunting total alkaloids (CSBTA) on cytochrome P450s in rats. Phytotherapy Research. 32(9). 1818–1827. 11 indexed citations
14.
Ren, Jie, et al.. (2018). Pharmacokinetics and tissue distribution of eupatilin and its metabolite in rats by an HPLC-MS/MS method. Journal of Pharmaceutical and Biomedical Analysis. 159. 113–118. 11 indexed citations
15.
16.
Qiu, Zhixia, Aiyun Li, Jiaojiao Yu, et al.. (2017). The role of curcumin in disruption of HIF-1α accumulation to alleviate adipose fibrosis via AMPK-mediated mTOR pathway in high-fat diet fed mice. Journal of Functional Foods. 33. 155–165. 12 indexed citations
17.
Dai, Yu, Cuiyun Li, Zhixia Qiu, et al.. (2016). Pharmacokinetics and pharmacodynamics evaluation of a thermosensitive chitosan based hydrogel containing liposomal doxorubicin. European Journal of Pharmaceutical Sciences. 92. 137–145. 36 indexed citations
18.
Li, Ning, Qinglong Guo, Hui Ji, et al.. (2011). Inhibitory effects of wogonin on catalytic activity of cytochrome P450 enzyme in human liver microsomes. European Journal of Drug Metabolism and Pharmacokinetics. 36(4). 249–256. 16 indexed citations
19.
He, Jiake, Zhixia Qiu, Ning Li, et al.. (2011). Effects of SLCO1B1 polymorphisms on the pharmacokinetics and pharmacodynamics of repaglinide in healthy Chinese volunteers. European Journal of Clinical Pharmacology. 67(7). 701–707. 29 indexed citations
20.
Yang, Lu, Jing Zhu, Xijing Chen, et al.. (2009). Identification of Human UDP-Glucuronosyltransferase Isoforms Responsible for the Glucuronidation of Glycyrrhetinic Acid. Drug Metabolism and Pharmacokinetics. 24(6). 523–528. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jingwei Tian Breakdown of academic impact, for papers by Lijun Zhang Breakdown of academic impact, for papers by Qianmei Zhou Breakdown of academic impact, for papers by Feng Jin Breakdown of academic impact, for papers by Shaoyu Wu Breakdown of academic impact, for papers by Amir R. Afshari Breakdown of academic impact, for papers by Jiayi Sun Breakdown of academic impact, for papers by Jianxin Pang Breakdown of academic impact, for papers by Lipeng Xu Breakdown of academic impact, for papers by Anna L. Greenshields
Rankless by CCL
2026